...diagnostic company LipoScience for $5.25 per share in cash, or about $85.4 million. LabCorp said LipoScience’s...
...personalize management of heart disease. At Sept. 30, LipoScience reported $29.6 million in nine-month revenue. LipoScience Inc....

...water at year end (see "IPO Performance," A7) . Among the three in the red, LipoScience Inc....
...Calif. Intarcia Therapeutics Inc. , Boston, Mass. KaloBios Pharmaceuticals Inc. (NASDAQ:KBIO), South San Francisco, Calif. LipoScience Inc....
...Chg from lockup Adj lockup chg (B) Pre-lockup vol % (C) Post-lockup vol % (C) LipoScience Inc....

...$M Chg from lockup Adj lockup chg (B) Chg from IPO Adj IPO chg (B) LipoScience Inc....

...or those that limped out the door in the first place. After initially trading up, LipoScience Inc....
...It closed the day off $1.96 (23%) to $6.50. Gordon noted that diagnostic companies like LipoScience...
...Md. Iroko Pharmaceuticals LLC , Philadelphia, Pa. KaloBios Pharmaceuticals Inc. (NASDAQ:KBIO), South San Francisco, Calif. LipoScience Inc....

...NASDAQ:KBIO) 1/31/13 $70.0 $193.0 $136.8 -29% Stemline Therapeutics Inc. (NASDAQ:STML) 1/28/13 $38.2 $74.6 $296.4 297% LipoScience Inc....

...NASDAQ:KBIO) 1/31/13 $70.0 $193.0 $121.4 -37% Stemline Therapeutics Inc. (NASDAQ:STML) 1/28/13 $38.2 $74.6 $249.8 235% LipoScience Inc....

...NASDAQ:KBIO) 1/31/13 $70.0 $193.0 $144.8 -25% Stemline Therapeutics Inc. (NASDAQ:STML) 1/28/13 $38.2 $74.6 $85.1 14% LipoScience Inc....

...transplant company APT Pharmaceuticals Inc. , chemistry platform company Concert Pharmaceuticals Inc. , diagnostic play LipoScience Inc....

...to $51.8 million. The company, which closed Friday at $10.68, has 14.6 million shares outstanding. LipoScience Inc....